BRUNO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 15.135
EU - Europa 1.992
AS - Asia 1.797
SA - Sud America 254
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 37
OC - Oceania 2
Totale 19.363
Nazione #
US - Stati Uniti d'America 15.035
SG - Singapore 814
DE - Germania 610
CN - Cina 419
IT - Italia 279
RU - Federazione Russa 276
BR - Brasile 202
UA - Ucraina 201
IE - Irlanda 155
VN - Vietnam 148
GB - Regno Unito 138
HK - Hong Kong 129
SE - Svezia 86
FR - Francia 83
BD - Bangladesh 72
CA - Canada 65
FI - Finlandia 60
JP - Giappone 51
KR - Corea 45
NL - Olanda 31
IN - India 22
AR - Argentina 20
ZA - Sudafrica 20
BE - Belgio 15
PL - Polonia 14
ID - Indonesia 13
UZ - Uzbekistan 13
MX - Messico 12
TR - Turchia 12
AT - Austria 9
CZ - Repubblica Ceca 9
PH - Filippine 9
CO - Colombia 8
EC - Ecuador 8
IQ - Iraq 7
SA - Arabia Saudita 7
NI - Nicaragua 6
PY - Paraguay 6
IL - Israele 5
CH - Svizzera 4
DK - Danimarca 4
ES - Italia 4
MY - Malesia 4
NG - Nigeria 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
DZ - Algeria 3
EU - Europa 3
IR - Iran 3
KG - Kirghizistan 3
NP - Nepal 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
LB - Libano 2
LT - Lituania 2
PE - Perù 2
RO - Romania 2
SC - Seychelles 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LY - Libia 1
MA - Marocco 1
MQ - Martinica 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 19.226
Città #
Woodbridge 4.157
Wilmington 3.251
Houston 2.877
Singapore 508
Ann Arbor 450
Chandler 443
Ashburn 427
Fairfield 354
San Jose 263
Dallas 192
Jacksonville 179
Beijing 170
Dublin 153
New York 130
Hong Kong 128
Seattle 124
The Dalles 122
Dearborn 115
Cambridge 110
Medford 110
Santa Clara 96
Rome 82
Council Bluffs 75
Los Angeles 72
Ho Chi Minh City 60
Zhengzhou 53
Lawrence 50
Munich 49
Tokyo 44
Lauterbourg 34
Buffalo 32
Hanoi 29
São Paulo 29
Moscow 28
Chicago 23
Denver 22
Milan 20
Montreal 20
San Diego 20
London 18
Brooklyn 17
Orem 17
North Bergen 16
Atlanta 15
Brussels 15
Hefei 15
Johannesburg 15
Mülheim 14
Wuhan 14
Amsterdam 12
Columbus 12
Helsinki 12
Nanjing 12
Toronto 12
Boardman 11
Norwalk 11
Palo Alto 11
Phoenix 11
University Park 11
Warsaw 11
Boston 10
Frankfurt am Main 10
Shanghai 10
Chennai 9
Menlo Park 9
San Francisco 9
Brno 8
Manchester 8
Colorado Springs 7
Creede 7
Mexico City 7
Mountain View 7
Nuremberg 7
Paris 7
Philadelphia 7
Rio de Janeiro 7
Stockholm 7
Ankara 6
Biên Hòa 6
Center 6
Guangzhou 6
Kunming 6
Managua 6
Nürnberg 6
Palermo 6
Redondo Beach 6
Turku 6
Burago di Molgora 5
Da Nang 5
Jakarta 5
Naples 5
Pittsburgh 5
Redwood City 5
Riyadh 5
Seoul 5
Verona 5
Baltimore 4
Belo Horizonte 4
Brasília 4
Calgary 4
Totale 15.640
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 547
CD7 expression in acute myeloid leukemia 543
AML-M0: A review of laboratory features and proposal of new diagnostic criteria 524
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 523
Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis 519
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 516
All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias 505
P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia 494
Leukocyte alkaline-phosphatase score in plasma-cell dyscrasias - correlation with disease severity and circulating levels of granulocyte-colony-stimulating factor 489
Biological profile of 23 cases of minimally differentiated acute myeloid leukemia (AML-MO) and its clinical implications 489
Multiparametric analysis for the enumeration of CD34+ cells from bone marrow and stimulated peripheral blood 484
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 481
Diagnosis of acute myeloid leukemia and system Coulter VCS 479
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 478
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia 476
Biological features of acute myeloid leukemia in the elderly 473
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 462
AML-M0: a biological and clinical profile 461
Biological pattern of AML-M0 versus AML-M1: Response 452
Minimally differentiated acute myeloid-leukemia (aml-mo): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases 448
Evaluation of biological features of cord blood units collected with different methods after cesarean section 447
Contribution of immunophenotypic and genotypic analysis to the diagnosis of acute leukemia 447
All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia 447
Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia 445
Red blood cell depletion and cryopreservation of umbilical cord blood (UCB) 442
Minimally differentiated acute myeloid leukemia (AML-MO): A distinct clinico-biologic entity with poor prognosis 432
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 432
P-glycoprotein expression in de novo acute myeloid leukemia 430
Lineage identification of acute leukemias: relevance of immunological and ultrastruttural techniques 424
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 411
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 391
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 374
Apoptosis and immaturity in acute myeloid leukemia 373
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 369
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 367
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia 362
Prognostic value of cell marker analysis in de-novo acute myeloid-leukemia 361
Prototypical proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 210
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 191
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 185
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 180
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 165
Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation 162
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 160
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 151
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 143
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 142
Corrigendum: Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 128
COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab 108
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 106
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 97
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 92
Osteopontin Is Associated with Multiple Sclerosis Relapses 91
Theoretical and therapeutic implications of the spasticity-plus syndrome model in multiple sclerosis 87
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 82
Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? 61
RBC depletion with Gelofusine in allogeneic hematopoietic stem cell transplantation 25
Totale 19.363
Categoria #
all - tutte 48.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 0 0 0 0 10 85 24 24 50 59 31 171
2022/2023947 91 84 85 114 68 212 81 47 92 15 39 19
2023/2024312 44 7 12 2 31 117 10 1 2 3 24 59
2024/20251.280 42 345 175 55 32 52 73 68 115 128 113 82
2025/20262.453 249 110 398 199 181 124 334 250 256 204 89 59
2026/2027889 102 117 379 281 10 0 0 0 0 0 0 0
Totale 19.363